<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01988571</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00038639</org_study_id>
    <secondary_id>U10CA081851</secondary_id>
    <secondary_id>1R01HL118740-01</secondary_id>
    <secondary_id>REBACCCWFU 98213</secondary_id>
    <secondary_id>NCI-2013-01760</secondary_id>
    <nct_id>NCT01988571</nct_id>
  </id_info>
  <brief_title>Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)</brief_title>
  <official_title>Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to see if Atorvastatin(Lipitor) 40 mg by mouth daily&#xD;
      decreases the chance of developing heart problems in women receiving adjuvant&#xD;
      anthracycline-based chemotherapy for breast cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      Specific Aim 1:&#xD;
&#xD;
      To determine if Atorvastatin(Lipitor) administration preserves LVEF 24 months after&#xD;
      initiation of Anthracycline-based adjuvant therapy for adjuvant treatment of breast cancer.&#xD;
&#xD;
      Specific Aim 2:&#xD;
&#xD;
      To determine if baseline to 6-month differences in LVEF predict baseline to 24-month&#xD;
      differences in LVEF after Anthracycline-based adjuvant therapy and concomitant atorvastatin&#xD;
      therapy.&#xD;
&#xD;
      To achieve these aims, we will perform a double-blind, placebo-controlled, randomized&#xD;
      clinical trial of 0 or 40 mg of atorvastatin/day in 250 women scheduled to receive&#xD;
      Anthracycline-based adjuvant therapy for treatment of adjuvant breast cancer. We will use&#xD;
      innovative noninvasive magnetic resonance imaging (MRI) procedures to accurately measure&#xD;
      LVEF. In addition, we will measure LV volumes, myocardial strain, fibrosis, aortic pulse wave&#xD;
      velocity (PWV) and wall thickness, all factors that can influence LVEF by altering LV&#xD;
      pre-load, after-load, and contractility.19,20 Advanced serum biomarkers will be measured that&#xD;
      assess for the presence of oxidative/nitrosative stress, systemic inflammation and&#xD;
      circulating neurohormones that also may influence LVEF.&#xD;
&#xD;
      This study will test a new clinical paradigm to manage breast cancer: primary prevention of&#xD;
      Anthracycline-based adjuvant therapy-related LV dysfunction using pre-treatment with low-cost&#xD;
      statins. In addition, this trial will be the first systematic collection of data regarding&#xD;
      the mechanism(s) and time course by which LV dysfunction and subsequent CHF evolve in women&#xD;
      given Anthracycline-based adjuvant therapy for adjuvant breast cancer. These data will be&#xD;
      useful to physicians trying to determine the optimal cardiac protection strategies when&#xD;
      administering adjuvant chemotherapeutic regimens to their breast cancer patients. The&#xD;
      objective of this research is to use inexpensive medications to preserve CV health and&#xD;
      thereby improve overall survival in the growing number of breast cancer patients.&#xD;
&#xD;
      SECONDARY OBJECTIVES&#xD;
&#xD;
      Specific Aim 1:&#xD;
&#xD;
      To document the effect of Atorvastatin (Lipitor) on cognitive function using a battery of&#xD;
      neurocognitive tests (HVLT, Rey-Osterreith Figure, COWA, Trail-making Parts A and B, Digit&#xD;
      Span and Grooved Pegboard) in breast cancer patients receiving an anthracycline.&#xD;
&#xD;
      Specific Aim 2:&#xD;
&#xD;
      To document the effect of Atorvastatin(Lipitor) on self-reported quality of life using&#xD;
      validated questionnaires (PROMIS including: General form, Cog Concerns, Cog Abilities,&#xD;
      Fatigue, Pain intensity and interference, Sleep Disturbance, Physical Functioning and Social&#xD;
      Functioning) in breast cancer patients receiving an anthracycline.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2014</start_date>
  <completion_date type="Actual">September 24, 2020</completion_date>
  <primary_completion_date type="Actual">September 24, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine if Atorvastatin (Lipitor) administration preserves LV Function</measure>
    <time_frame>24 months</time_frame>
    <description>Clinical measurements obtained from Cardiac MRI Left Ventricular Ejection Fraction Left Ventricular Volume Strain Fibrosis Wall Thickness Pulse Wave Velocity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Document the effect of atorvastatin on cognitive function</measure>
    <time_frame>24 months</time_frame>
    <description>Measured by the Controlled Oral Word Association Test, Hopkins Verbal Learning Test - revised, Trail Making Test (A and B), Rey-Osterrieth Complex Figure - modified, Digit Span Test and Grooved Pegboard.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Document effect of Atorvastatin on self-reported quality of life</measure>
    <time_frame>24 months</time_frame>
    <description>Patient reported quality of life outcomes obtained from PROMIS questionnaires. Cognitive concerns; Cognitive abilities; Fatigue; Mood; Pain Intensity and Interference; Sleep Disturbance and Physical Function.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">279</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Arm 1 - Atorvastatin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One 40 mg Atorvastatin tablet each morning by mouth for 24 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2 - Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One placebo tablet each morning by mouth for 24 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atorvastatin</intervention_name>
    <description>40 mg tablet taken by mouth each morning for 24 months.</description>
    <arm_group_label>Arm 1 - Atorvastatin</arm_group_label>
    <arm_group_label>Arm 2 - Placebo</arm_group_label>
    <other_name>Lipitor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>One placebo tablet taken each morning orally for 24 months.</description>
    <arm_group_label>Arm 2 - Placebo</arm_group_label>
    <other_name>sugar pill</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Newly diagnosed Stage I-III female breast cancer (including inflammatory breast&#xD;
             cancer)&#xD;
&#xD;
          -  Scheduled to receive adjuvant chemotherapy with an Anthracycline (doxorubicin and&#xD;
             epirubicin)&#xD;
&#xD;
          -  30 to 80 years of age&#xD;
&#xD;
          -  LVEF &gt; 50% (Most recent within the last 5 years)&#xD;
&#xD;
          -  Prior chemotherapy regimen not containing anthracyclines is allowed&#xD;
&#xD;
          -  Able to hold breath for 15 seconds&#xD;
&#xD;
          -  Prior cancers allowed if no evidence of disease in last 5 years&#xD;
&#xD;
          -  ECOG 0 or 1&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior use of lipid-lowering therapy within the last 6 months&#xD;
&#xD;
          -  Current postmenopausal hormone-replacement therapy&#xD;
&#xD;
          -  Uncontrolled hypertension (systolic blood pressure &gt;190 mm Hg or diastolic blood&#xD;
             pressure &gt;100 mm Hg)&#xD;
&#xD;
          -  Scheduled to receive neoadjuvant chemotherapy with an anthracycline&#xD;
&#xD;
          -  No active liver disease allowed&#xD;
&#xD;
          -  Uncontrolled hypothyroidism&#xD;
&#xD;
          -  Recent history (within past 3 years) of alcohol or drug abuse, inflammatory conditions&#xD;
             such as lupus or inflammatory bowel disease, use of immunosuppressant agents, or&#xD;
             another medical condition that might compromise safety or the successful completion of&#xD;
             the study.&#xD;
&#xD;
          -  Patients with ferromagnetic cerebral aneurysm clips or other intraorbital/intracranial&#xD;
             metal;pacemakers, defibrillators, functioning neurostimulator devices or other&#xD;
             implanted electronic devices.&#xD;
&#xD;
          -  Unstable angina; significant ventricular arrhythmias (&gt;20 PVCs/min due to gating&#xD;
             difficulty) atrial fibrillation with uncontrolled ventricular response; coronary&#xD;
             artery disease; acute myocardial infarction within 28 days&#xD;
&#xD;
          -  Current use of CYP 3A4 inhibitors. These include Clarithromycin, HIV protease&#xD;
             inhibitors, Itraconazole, grapefruit juice, Cyclosporine, Rifampin or Digoxin&#xD;
&#xD;
          -  Current or history of hepatic dysfunction&#xD;
&#xD;
          -  Unable to provide informed consent&#xD;
&#xD;
          -  Claustrophobia&#xD;
&#xD;
          -  Planning to move within 24 months of trial enrollment&#xD;
&#xD;
          -  Pregnant or breast-feeding&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregory Hundley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kaiser Permanente Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Georgetown University Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Chicago Comprehensive Cancer Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas-Wichita Medical Arts Tower</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Wichita</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center Jefferson</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Health at Butterworth Campus</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital-Royal Oak</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital - Troy</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48085</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint John's Hospital - Healtheast</name>
      <address>
        <city>Maplewood</city>
        <state>Minnesota</state>
        <zip>55109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abbott-Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Park Nicollet Clinic - Saint Louis Park</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regions Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>United Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mission Hospital</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hope Women's Cancer Centers-Asheville</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cone Health Cancer Center at Alamance Regional</name>
      <address>
        <city>Burlington</city>
        <state>North Carolina</state>
        <zip>27215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novant Health Presbyterian Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oncology Specialists of Charlotte</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cone Health Cancer Center</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novant Health Cancer Institute - Huntersville</name>
      <address>
        <city>Huntersville</city>
        <state>North Carolina</state>
        <zip>28078</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern Oncology Specialists-Huntersville</name>
      <address>
        <city>Huntersville</city>
        <state>North Carolina</state>
        <zip>28078</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novant Health Cancer Institute - Kernersville</name>
      <address>
        <city>Kernersville</city>
        <state>North Carolina</state>
        <zip>27284</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novant Health Cancer Specialists-Matthews</name>
      <address>
        <city>Matthews</city>
        <state>North Carolina</state>
        <zip>28105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novant Health Forsyth Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novant Health Oncology Specialists</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbus Oncology and Hematology Associates Inc</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Doctors Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43228</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Delaware Health Center-Grady Cancer Center</name>
      <address>
        <city>Delaware</city>
        <state>Ohio</state>
        <zip>43015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Genesis Healthcare System Cancer Care Center</name>
      <address>
        <city>Zanesville</city>
        <state>Ohio</state>
        <zip>43701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania/Abramson Cancer Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prisma Health Cancer Institute - Easley</name>
      <address>
        <city>Easley</city>
        <state>South Carolina</state>
        <zip>29640</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prisma Health Cancer Institute - Butternut</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prisma Health Cancer Institute - Faris</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prisma Health Cancer Institute - Eastside</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prisma Health Cancer Institute - Seneca</name>
      <address>
        <city>Seneca</city>
        <state>South Carolina</state>
        <zip>29672</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centra Lynchburg Hematology-Oncology Clinic Inc</name>
      <address>
        <city>Lynchburg</city>
        <state>Virginia</state>
        <zip>24501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Cancer Institute</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University/Massey Cancer Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shenandoah Oncology PC</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora Cancer Care-Southern Lakes VLCC</name>
      <address>
        <city>Burlington</city>
        <state>Wisconsin</state>
        <zip>53105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora Cancer Care-Grafton</name>
      <address>
        <city>Grafton</city>
        <state>Wisconsin</state>
        <zip>53024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vince Lombardi Cancer Clinic - Oshkosh</name>
      <address>
        <city>Oshkosh</city>
        <state>Wisconsin</state>
        <zip>54904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora Medical Center in Summit</name>
      <address>
        <city>Summit</city>
        <state>Wisconsin</state>
        <zip>53066</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>November 1, 2013</study_first_submitted>
  <study_first_submitted_qc>November 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2013</study_first_posted>
  <last_update_submitted>July 23, 2021</last_update_submitted>
  <last_update_submitted_qc>July 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stage I breast cancer</keyword>
  <keyword>Stage II breast cancer</keyword>
  <keyword>Stage III breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atorvastatin</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/71/NCT01988571/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <pending_results>
    <submitted>September 29, 2021</submitted>
    <returned>October 28, 2021</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

